Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissues
Carly E. Starke, … , David A. Price, Jason M. Brenchley
Carly E. Starke, … , David A. Price, Jason M. Brenchley
Published October 29, 2019
Citation Information: J Clin Invest. 2020;130(2):789-798. https://doi.org/10.1172/JCI129161.
View: Text | PDF
Research Article AIDS/HIV Immunology

SIV-specific CD8+ T cells are clonotypically distinct across lymphoid and mucosal tissues

  • Text
  • PDF
Abstract

CD8+ T cell responses are necessary for immune control of simian immunodeficiency virus (SIV). However, the key parameters that dictate antiviral potency remain elusive, conceivably because most studies to date have been restricted to analyses of circulating CD8+ T cells. We conducted a detailed clonotypic, functional, and phenotypic survey of SIV-specific CD8+ T cells across multiple anatomical sites in chronically infected rhesus macaques with high (>10,000 copies/mL plasma) or low burdens of viral RNA (<10,000 copies/mL plasma). No significant differences in response magnitude were identified across anatomical compartments. Rhesus macaques with low viral loads (VLs) harbored higher frequencies of polyfunctional CXCR5+ SIV-specific CD8+ T cells in various lymphoid tissues and higher proportions of unique Gag-specific CD8+ T cell clonotypes in the mesenteric lymph nodes relative to rhesus macaques with high VLs. In addition, public Gag-specific CD8+ T cell clonotypes were more commonly shared across distinct anatomical sites than the corresponding private clonotypes, which tended to form tissue-specific repertoires, especially in the peripheral blood and the gastrointestinal tract. Collectively, these data suggest that functionality and tissue localization are important determinants of CD8+ T cell–mediated efficacy against SIV.

Authors

Carly E. Starke, Carol L. Vinton, Kristin Ladell, James E. McLaren, Alexandra M. Ortiz, Joseph C. Mudd, Jacob K. Flynn, Stephen H. Lai, Fan Wu, Vanessa M. Hirsch, Samuel Darko, Daniel C. Douek, David A. Price, Jason M. Brenchley

×

Figure 2

Expression of CXCR5 on SIV-specific CD8+ T cells correlates inversely with VL.

Options: View larger image (or click on image) Download as PowerPoint
Expression of CXCR5 on SIV-specific CD8+ T cells correlates inversely wi...
(A) Frequency of CD4+ T cells in the GI tract. (B) Number of CD4+ T cells in the peripheral blood. (C) Correlation between the frequency of SIV-specific CD8+ T cells in the GI tract and the frequency of CD4+ T cells in the GI tract. (D) Correlation between the frequency of SIV-specific CD8+ T cells in the GI tract and the number of CD4+ T cells in the peripheral blood. (E) Frequency of CXCR5+ SIV-specific CD8+ T cells in the spleen. (F) Correlation between the frequency of CXCR5+ SIV-specific CD8+ T cells in the spleen and the amount of viral DNA in CD4+ TFH cells. (G) Correlation between the frequency of CXCR5+ SIV-specific CD8+ T cells in the spleen and VL. Data were acquired from Mamu-A*01+ and Mamu-A*02+ rhesus macaques (n = 22). Horizontal bars indicate median values (A, B, and E). Significance was determined using the Mann-Whitney U test (A, B, and E) or Spearman’s rank correlation with linear regression (C, D, F, and G).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts